MYX shares will go up in value. The current and future product line is in womens health and skin care issues. Womens health in particular wont go away in a depression/recession. MYX has a good business model. Management will improve the costs and it will succeed long term. Its not a hyped up tech company selling access to software - whose shares can dive 95%. The company has a great market and great opportunity. Its debt free with some cash to invest wisely... Opportunities may present themselves with more hormonal treatments for women from Mithra. No more generics !!! No more debt !!!! the mistakes of the teva purchase have been written out of the equation.... Business takes time to happen - just be patient.
MYX Price at posting:
$4.07 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)